טוען...
The splicing-factor oncoprotein SF2/ASF activates mTORC1
The splicing factor SF2/ASF is an oncoprotein that is up-regulated in many cancers and can transform immortal rodent fibroblasts when slightly overexpressed. The mTOR signaling pathway is activated in many cancers, and pharmacological blockers of this pathway are in clinical trials as anticancer dru...
שמור ב:
| Main Authors: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | English |
| יצא לאור: |
National Academy of Sciences
2008
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2563124/ https://ncbi.nlm.nih.gov/pubmed/18832178 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0801376105 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|